These resources are accessible on WADAs Anti-Doping Education and Learning Platform (ADEL)
My recommended Melanotan 2 protocol is 0.25 mg injected subcutaneously, 1-2 times per week, which minimizes MC4R-driven side effects while still driving melanogenesis through MC1R
That said, if you have TFL but not Medicare Part D, you may not have access to the program
2.2 Construction of cDNA cDNA encoding the following constructs has been previously described: C-terminally labeled super yellow fluorescent protein 2 (SYFP2) and Nano Luciferase (NLuc)-labeled human GLP-1R and GIPR, arrestin3NLuc, arrestin3SYFP2 (Arr3SYFP2), and mCherry CAAX ( vice versa (Table 1)
Digital tools can make this even easier by automatically tracking your injection details
One common issue is determining the quantity that indicates an intent to distribute